MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

Brigitte Wildemann(Heidelberg University), Carsten Lukas(University Hospitals of the Ruhr-University of Bochum), Eberhard Siebert(Charité - Universitätsmedizin Berlin), Nadja Borisow(Max Delbrück Center), Florence Pache(Heidelberg University), Nasrin Asgari(University of Southern Denmark), Marius Ringelstein(Medizinische Hochschule Hannover), Jürgen Haas(Heidelberg University), Kalliopi Pitarokoili(Max Delbrück Center), Alexander Schwarz(Society for Chemical Engineering and Biotechnology), Klemens Ruprecht(Charité - Universitätsmedizin Berlin), Orhan Aktaş(Heinrich Heine University Düsseldorf), Alexander U. Brandt(Eli Lilly (United States)), Friedemann Paul(Max Delbrück Center), Mathias Buttmann(University of Würzburg), Markus Reindl(Innsbruck Medical University), Corinna Trebst(Medizinische Hochschule Hannover), Mirjam Korporal‐Kuhnke(University Hospital Heidelberg), Hanna Zimmermann(Humboldt-Universität zu Berlin), Joseph Kuchling(Max Delbrück Center), Marco Capobianco(Ospedale San Luigi Gonzaga), Kathrin Schanda(Innsbruck Medical University), Alexander Winkelmann(University of Rostock), Martin W. Hümmert(Medizinische Hochschule Hannover), Sven Jarius(Heidelberg University), Oliver Stich(University of Freiburg), Lena-Alexandra Beume(University of Freiburg), Kaï Fechner(Euroimmun Medizinische Labordiagnostika (Germany)), Ingo Kleiter(Dentsply Sirona (United States)), Diego Franciotta(Ospedale Santa Chiara)
Journal of Neuroinflammation
October 28, 2016
Cited by 896


Related Papers